Azenosertib median duration of response (mDOR) updated to 6.3 months in the ongoing DENALI Part 1b clinical trial in patients with ...
It’s actually Eden’s “Boudior” — the Vivienne Westwood fragrance was discontinued in 2019. Eden is one among a growing number ...
Endo, Inc. ("Endo" or the "Company") (OTCQX: NDOI) today announced it has entered into a definitive agreement to divest its International Pharmaceuticals ...
Retired regulators suggest ways to tackle the menace of counterfeit drugs in the market: Peethaambaran Kunnathoor, Chennai Monday, March 17, 2025, 08:00 Hrs [IST] Since the counte ...
The list extends into the pharma industry, including Pfizer, GSK, and Novo Nordisk. On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ...
Endo achieved 2024 revenues and adjusted EBITDA expectations, while progressing the Company's strategic prioritiesXIAFLEX® hit record revenues of $516 million in 2024, up 9% versus 2023The Company ...
We recently compiled a list of the 10 Best Low Risk Stocks To Buy in 2025. In this article, we are going to take a look at ...
All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.
5dOpinion
The Daily Caller on MSNEXCLUSIVE: How Chris Wright Plans To Help America Climb Out Of Energy ‘Hole’ Dug By Biden AdminEnergy Secretary Chris Wright explained his plans to fortify America’s fragile power grid and a host of other energy policy ...
Morgan Stanley analyst Vikram Purohit maintained a Hold rating on Ascendis Pharma (ASND – Research Report) today and set a price target of ...
Pharma brands that fail to evolve risk losing relevance in a world where patients demand more control, transparency, and ...
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results